Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Labeller names
- 2
- Live patents
- 20
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.
| Dosage form | NDCs |
|---|---|
| liquid | 1 |
| patch | 1 |
| solution | 1 |
| Route | NDCs |
|---|---|
| oral | 2 |
| topical | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| scilex pharmaceuticals inc. | 2 |
| scilex pharmaceuticals inc. | 1 |
Exclusivity
Patents and exclusivities
20| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10765640 | ZTLIDOlidocaine | product | May 2031 |
| 10765749 | ZTLIDOlidocaine | product | May 2031 |
| 11278623 | ZTLIDOlidocaine | product | May 2031 |
| 11786455 | ZTLIDOlidocaine | product | May 2031 |
| 11793766 | ZTLIDOlidocaine | use | May 2031 |
| 9283174 | ZTLIDOlidocaine | product | May 2031 |
| 9925264 | ZTLIDOlidocaine | product | May 2031 |
| 9931403 | ZTLIDOlidocaine | product | May 2031 |
| 10376527 | ELYXYBcelecoxib | product | May 2036 |
| 10722456 | ELYXYBcelecoxib | product | May 2036 |
| 10799517 | ELYXYBcelecoxib | product | May 2036 |
| 9572819 | ELYXYBcelecoxib | product | May 2036 |
| 9795620 | ELYXYBcelecoxib | product | May 2036 |
| 9949990 | ELYXYBcelecoxib | product | May 2036 |
| 10383820 | GLOPERBAcolchicine | product | Nov 2036 |
| 10383821 | GLOPERBAcolchicine | product | Nov 2036 |
| 12274751 | GLOPERBAcolchicine | use | Nov 2036 |
| 12514819 | GLOPERBAcolchicine | use | Nov 2036 |
| 9907751 | GLOPERBAcolchicine | product | Nov 2036 |
| 10226423 | GLOPERBAcolchicine | product | Dec 2037 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ELYXYB - celecoxib | celecoxib | liquid, oral | 69557-333NDA |
| Gloperba | Colchicine | solution, oral | 69557-222NDA |
| Ztlido | Lidocaine | patch, topical | 69557-111NDA |
Compare
Other companies listing colchicine
- Zydus Lifesciences Limited12 sites · 717 NDC
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- Takeda Pharmaceuticals U.S.A., Inc.7 sites · 226 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- SOLARA ACTIVE PHARMA SCIENCES LIMITED6 sites · 40 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
- Macleods Pharmaceuticals Limited5 sites · 390 NDC
- Strides Pharma Science Limited5 sites · 230 NDC
- Par Health USA, LLC5 sites · 211 NDC
- Micro Labs Limited5 sites · 141 NDC
Enquiry
Common questions
- Is Scilex Pharmaceuticals Inc. FDA approved?
- Scilex Pharmaceuticals Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Scilex Pharmaceuticals Inc. make?
- 3 products are listed under Scilex Pharmaceuticals Inc. in the openFDA NDC Directory, most often as liquid; patch; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.